CRTAC1: a novel indicator of lung involvement in SSc
Systemic levels of CRTAC1 are decreased in SSc patients, especially among those with ILD, reduced lung function and elevated disease activity. Our findings establish CRTAC1 as a promising biomarker for pulmonary involvement in SSc.
Authors
- Jiří Baloun (ORCID: https://orcid.org/0000-0001-7029-1550)
- Hana Štorkánová (ORCID: https://orcid.org/0000-0002-6416-8385)
- Ladislav Šenolt (ORCID: https://orcid.org/0000-0001-5500-7312)
- Michal Tomčík (ORCID: https://orcid.org/0000-0002-8616-7850)
- Sabína Oreská (ORCID: https://orcid.org/0000-0002-9912-725X)
- Radim Bečvář (ORCID: https://orcid.org/0000-0003-0022-3135)
- A. Prokopcova (ORCID: https://orcid.org/0000-0002-8947-5955)
Institutions
- Charles University (CZ)
- Institute of Rheumatology (CZ)
Publication Details
- Journal
- Lara D. Veeken
- Published
- 2025-05-23
- DOI
- https://doi.org/10.1093/rheumatology/keaf269
- Primary Topic
- Systemic Sclerosis and Related Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00